69304-42-3

Basic information

• Product Name: (+)-3',5'-O-(1,1,3,3-Tetraisopropyl-1,3-disiloxanediyl)cytidine
• Synonyms: 3'-O,5'-O-[Oxybis(diisopropylsilanediyl)]cytidine;3'-O,5'-O-[Oxybis(diisopropylsilylene)]cytidine;4-amino-1-((6aR,8R,9R,9aS)-9-hydroxy-2,2,4,4-tetraisopropyltetrahydro-6H-furo[3,2-f][1,3,5,2,4]trioxadisilocin-8-yl)pyrimidin-2(1H)-one;(+)-3',5'-O-(1,1,3,3-TETRAISOPROPYL-1,3-DISILOXANEDIYL)CYTIDINE;(+)-3',5'-O-(1,1,3,3-tetraisopropyl-1,3-disiloxan;(1,1,3,3-tetraisopropyl-1,3-disiloxanediyl)cytidine;3'-O,5'-O-(1,1,3,3-Tetraisopropylpropanedisiloxane-1,3-diyl)cytidine;1-[(6AR,8R,9R,9AS)-9-HYDROXY-2,2,4,4-TETRAISOPROPYLTETRAHYDRO-6H-FURO[3,2-F][1,3,5,2,4]TRIOXADISILOCIN-8-YL]-4-AMINO-2(1H)-PYRIMIDINONE(WXG01294)
• CAS NO: 69304-42-3
• Molecular Formula: C₂₁H₃₉N₃O₆Si₂
• Molecular Weight: 485.72
• Mol File: 69304-42-3.mol
• Article Data: 25

Chemical Properties

• Melting Point: 248-250 °C(lit.)
• Boiling Point: 517.7 °C at 760 mmHg
• Flash Point: 266.9 °C
• Appearance: /
• Density: 1.2 g/cm³
• PKA: 13.18±0.40(Predicted)
• CAS DataBase Reference: (+)-3',5'-O-(1,1,3,3-Tetraisopropyl-1,3-disiloxanediyl)cytidine(CAS DataBase Reference)
• NIST Chemistry Reference: (+)-3',5'-O-(1,1,3,3-Tetraisopropyl-1,3-disiloxanediyl)cytidine(69304-42-3)
• EPA Substance Registry System: (+)-3',5'-O-(1,1,3,3-Tetraisopropyl-1,3-disiloxanediyl)cytidine(69304-42-3)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 26-36
• WGK Germany: 3
• Hazardous Substances Data: 69304-42-3(Hazardous Substances Data)

Usage

General Description

(+)-3',5'-O-(1,1,3,3-Tetraisopropyl-1,3-disiloxanediyl)cytidine is a chemical compound that is utilized in biochemistry and molecular biology. It is a modified form of cytidine that contains a silicon-based linker molecule and is commonly used in the study of nucleic acid structure and function. This modified cytidine is often employed to probe the interactions and dynamics of RNA and DNA molecules, as well as to study the effects of chemical modifications on nucleic acid behavior. The unique structure of this compound allows researchers to manipulate and study nucleic acids in a precise and controlled manner, making it a valuable tool in the field of nucleic acid research.

Upstream product

• 69304-37-6 1,3-Dichloro-1,1,3,3-tetraisopropyldisiloxane 
• 58-96-8 uridine 
• 69304-43-4 1-[3,5-O-(1,1,3,3-tetraisopropyldisiloxane-1,3-diyl)-β-D-ribofuranosyl]-N⁴-benzoylcytosine 
• 74-89-5 methylamine 
• 85335-73-5 N₄-acetyl-3',5'-O-(tetraisopropyldisiloxane-1,3-diyl)cytidine 
• 75-04-7 ethylamine 
• 107-10-8 propylamine 
• 65-46-3 CYTIDINE 
• 119694-66-5 4-O-<(2,4,6-triisopropylphenyl)sulfonyl>-3',5'-O-(1,1,3,3-tetraisopropyldisiloxane-1,3-diyl)uridine 

Downstream Products

• 1491026-66-4 C₃₆H₆₀N₅O₁₀PSi₂ 
• 1491026-71-1 C₂₄H₃₂N₅O₈P 
• 1403568-00-2 C₂₀H₂₆N₇O₈P 
• 1605283-89-3 C₃₀H₄₂N₇O₁₀P 
• 1605283-90-6 C₂₆H₃₆N₇O₉P 
• 1605283-86-0 C₂₆H₃₆N₇O₉P 
• 1403574-71-9 C₂₂H₃₀N₇O₈P 
• 1605283-84-8 C₃₁H₄₂N₅O₁₀P 
• 1605283-80-4 C₃₁H₄₄N₅O₉P 
• 1605283-78-0 C₃₁H₄₄N₅O₉P 
• 1403249-81-9 C₂₁H₂₉N₄O₈PS 
• 1403249-80-8 C₂₂H₂₈N₇O₈P 
• 1403250-92-9 C₂₂H₃₂N₅O₈P 
• 1403250-39-4 C₁₉H₂₄ClN₆O₇P 

Relevant articles and documents

2′-: O -Trifluoromethylated RNA-a powerful modification for RNA chemistry and NMR spectroscopy

New RNA modifications are needed to advance our toolbox for targeted manipulation of RNA. In particular, the development of high-performance reporter groups facilitating spectroscopic analysis of RNA structure and dynamics, and of RNA-ligand interactions

MONONUCLEOTIDES HAVING A BIOREVERSIBLE DISULFIDE GROUP

The invention features a mononucleotide comprising a nucleobase bonded to a sugar having a 3'-carbon and a 5'-carbon, where the 5'-carbon is bonded to a phosphorus (V) atom of a phosphate group through an oxygen atom, the phosphorus (V) atom being bonded to (i) a disulfide bioreversible group through an oxygen atom; and (ii) (a) optionally substituted amino, optionally substituted alkoxy, optionally substituted aryloxy, or optionally substituted heteroaryloxy; or (b) the 3'-carbon through an oxygen atom. The invention also features methods of delivering the mononucleotide to a cell and methods of treating a subject having Hepatitis C.

2'-METHYL SUBSTITUTED NUCLEOSIDE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

The present invention relates to 2'-Methyl Substituted Nucleoside Derivatives of Formula (I): and pharmaceutically acceptable salts thereof, wherein R, R1, R2 and R3, are as defined herein. The present invention also relat